Published in Zentralbl Gynakol on December 01, 2003
Breast cancer susceptibility: current knowledge and implications for genetic counselling. Eur J Hum Genet (2008) 1.82
Genetic testing for familial/hereditary breast cancer-comparison of guidelines and recommendations from the UK, France, the Netherlands and Germany. J Community Genet (2011) 1.23
Identification of Novel Susceptibility Genes for Breast Cancer - Genome-Wide Association Studies or Evaluation of Candidate Genes? Breast Care (Basel) (2009) 0.96
Detected, yet not Diagnosed - Breast Cancer Screening with MRI Mammography in High-Risk Women. Breast Care (Basel) (2012) 0.81
[The genetic revolution-impact on therapy and prevention]. Internist (Berl) (2004) 0.75
A physical map of the human genome. Nature (2001) 12.39
Host response to EBV infection in X-linked lymphoproliferative disease results from mutations in an SH2-domain encoding gene. Nat Genet (1998) 3.94
The der(17)t(X;17)(p11;q25) of human alveolar soft part sarcoma fuses the TFE3 transcription factor gene to ASPL, a novel gene at 17q25. Oncogene (2001) 2.97
Mutational hot spot within a new RPGR exon in X-linked retinitis pigmentosa. Nat Genet (2000) 2.82
The BCL11 gene family: involvement of BCL11A in lymphoid malignancies. Blood (2001) 2.77
Mutations in the DAX-1 gene give rise to both X-linked adrenal hypoplasia congenita and hypogonadotropic hypogonadism. Nature (1994) 2.49
An L-type calcium-channel gene mutated in incomplete X-linked congenital stationary night blindness. Nat Genet (1998) 2.48
Simultaneous fluorescence immunophenotyping and interphase cytogenetics: a contribution to the characterization of tumor cells. J Histochem Cytochem (1992) 2.31
The complete form of X-linked congenital stationary night blindness is caused by mutations in a gene encoding a leucine-rich repeat protein. Nat Genet (2000) 2.08
MLL is fused to CBP, a histone acetyltransferase, in therapy-related acute myeloid leukemia with a t(11;16)(q23;p13.3). Proc Natl Acad Sci U S A (1997) 2.01
A new gene involved in X-linked mental retardation identified by analysis of an X;2 balanced translocation. Nat Genet (2000) 1.97
Inactivating mutations and overexpression of BCL10, a caspase recruitment domain-containing gene, in MALT lymphoma with t(1;14)(p22;q32). Nat Genet (1999) 1.96
Clinical, morphological, cytogenetic, and prognostic features of patients with myelodysplastic syndromes and del(5q) including band q31. Leukemia (2004) 1.90
Classification of non-bacterial osteitis: retrospective study of clinical, immunological and genetic aspects in 89 patients. Rheumatology (Oxford) (2006) 1.84
All patients with the T(11;16)(q23;p13.3) that involves MLL and CBP have treatment-related hematologic disorders. Blood (1997) 1.71
Numerical chromosome aberrations are present within the CD30+ Hodgkin and Reed-Sternberg cells in 100% of analyzed cases of Hodgkin's disease. Blood (1995) 1.64
Analysis of the OA1 gene reveals mutations in only one-third of patients with X-linked ocular albinism. Hum Mol Genet (1995) 1.64
Isolation of a candidate gene for Norrie disease by positional cloning. Nat Genet (1992) 1.55
Which compartments are involved in Philadelphia-chromosome positive chronic myeloid leukaemia? An answer at the single cell level by combining May-Grünwald-Giemsa staining and fluorescence in situ hybridization techniques. Br J Haematol (1997) 1.46
New insights into the biology of Philadelphia-chromosome-positive acute lymphoblastic leukaemia using a combination of May-Grünwald-Giemsa staining and fluorescence in situ hybridization techniques at the single cell level. Br J Haematol (1997) 1.43
Prognostic value of DNA ploidy and S-phase fraction in stage I endometrial carcinoma. Gynecol Oncol (1995) 1.40
SF3B1 mutations in myelodysplastic syndromes: clinical associations and prognostic implications. Leukemia (2011) 1.38
Mutations in a delta 8-delta 7 sterol isomerase in the tattered mouse and X-linked dominant chondrodysplasia punctata. jderry@immunex.com. Nat Genet (1999) 1.38
A comparison of BRCA1 mutation analysis by direct sequencing, SSCP and DHPLC. Hum Genet (1999) 1.37
Human immunoglobulin kappa light chain genes of subgroups II and III. Nucleic Acids Res (1985) 1.37
Cyclin D3 is a target gene of t(6;14)(p21.1;q32.3) of mature B-cell malignancies. Blood (2001) 1.36
Leukemia induction after a single retroviral vector insertion in Evi1 or Prdm16. Leukemia (2008) 1.35
Breastfeeding and breast cancer risk by age 50 among women in Germany. Cancer Causes Control (2000) 1.31
A novel gene, tendin, is strongly expressed in tendons and ligaments and shows high homology with chondromodulin-I. Dev Dyn (2001) 1.26
Molecular modelling of the Norrie disease protein predicts a cystine knot growth factor tertiary structure. Nat Genet (1993) 1.25
Patients with de novo acute myeloid leukaemia and complex karyotype aberrations show a poor prognosis despite intensive treatment: a study of 90 patients. Br J Haematol (2001) 1.21
Marrow fibrosis predicts early fatal marrow failure in patients with myelodysplastic syndromes. Leukemia (2007) 1.21
Molecular analysis of the CALM/AF10 fusion: identical rearrangements in acute myeloid leukemia, acute lymphoblastic leukemia and malignant lymphoma patients. Leukemia (2000) 1.18
Prevalence of Staphylococcus aureus and staphylococcal enterotoxins in raw pork and uncooked smoked ham--a comparison of classical culturing detection and RFLP-PCR. Int J Food Microbiol (2001) 1.16
Mutations in the candidate gene for Norrie disease. Hum Mol Genet (1992) 1.13
Association of PHB 1630 C>T and MTHFR 677 C>T polymorphisms with breast and ovarian cancer risk in BRCA1/2 mutation carriers: results from a multicenter study. Br J Cancer (2012) 1.12
Ten-year analysis of the prospective multicentre Chemo-N0 trial validates American Society of Clinical Oncology (ASCO)-recommended biomarkers uPA and PAI-1 for therapy decision making in node-negative breast cancer patients. Eur J Cancer (2013) 1.12
Overrepresentation of 3q and 8q material and loss of 18q material are recurrent findings in advanced human ovarian cancer. Genes Chromosomes Cancer (1996) 1.10
Identification of specific BRCA1 and BRCA2 variants by DHPLC. Hum Mutat (2000) 1.10
A highly sensitive, fast, and economical technique for mutation analysis in hereditary breast and ovarian cancers. Hum Mutat (1999) 1.07
Microsatellite instability in ovarian neoplasms. Br J Cancer (1995) 1.06
Mapping of the gene encoding human beta-defensin-2 (DEFB2) to chromosome region 8p22-p23.1. Genomics (1997) 1.05
Frequency of BRCA1 mutation 5382insC in German breast cancer patients. Gynecol Oncol (1999) 1.04
Epstein-Barr virus-negative boys with non-Hodgkin lymphoma are mutated in the SH2D1A gene, as are patients with X-linked lymphoproliferative disease (XLP). Hum Mol Genet (1999) 1.04
The V kappa genes of the L regions and the repertoire of V kappa gene sequences in the human germ line. Eur J Immunol (1993) 1.03
Assignment1 of human putative tumor suppressor genes ST13 (alias SNC6) and ST14 (alias SNC19) to human chromosome bands 22q13 and 11q24-->q25 by in situ hybridization. Cytogenet Cell Genet (1998) 1.03
Consensus guidelines for microarray gene expression analyses in leukemia from three European leukemia networks. Leukemia (2006) 1.03
A 3-cM commonly deleted region in 6q21 in leukemias and lymphomas delineated by fluorescence in situ hybridization. Genes Chromosomes Cancer (2000) 1.02
Wiskott-Aldrich syndrome: no strict genotype-phenotype correlations but clustering of missense mutations in the amino-terminal part of the WASP gene product. Hum Genet (1996) 1.02
A splice site mutation in the methyltransferase gene FTSJ1 in Xp11.23 is associated with non-syndromic mental retardation in a large Belgian family (MRX9). J Med Genet (2004) 1.01
Evidence for genetic heterogeneity of malignant hyperthermia susceptibility. Am J Hum Genet (1992) 1.01
The human immunoglobulin kappa locus. Characterization of the duplicated A regions. Eur J Immunol (1992) 1.01
Mutation screening of the BTK gene in 56 families with X-linked agammaglobulinemia (XLA): 47 unique mutations without correlation to clinical course. Pediatrics (1998) 1.01
Molecular cytogenetic delineation of a novel critical genomic region in chromosome bands 11q22.3-923.1 in lymphoproliferative disorders. Proc Natl Acad Sci U S A (1996) 1.00
BRCA1/2 testing: uptake, phenocopies, and strategies to improve detection rates in initially negative families. Clin Genet (2011) 0.99
Remarkable leukemogenic potency and quality of a constitutively active neurotrophin receptor, deltaTrkA. Leukemia (2007) 0.99
Detection of translocations affecting the BCL6 locus in B cell non-Hodgkin's lymphoma by interphase fluorescence in situ hybridization. Leukemia (2001) 0.98
A novel pedigree with heterozygous germline RUNX1 mutation causing familial MDS-related AML: can these families serve as a multistep model for leukemic transformation? Leukemia (2009) 0.97
Non-radioactive labeling and detection of nucleic acids. III. Applications of the digoxigenin system. Biol Chem Hoppe Seyler (1990) 0.97
Aerobic exercise as a therapy option for migraine: a pilot study. Int J Sports Med (2011) 0.97
Altered miRNA and gene expression in acute myeloid leukemia with complex karyotype identify networks of prognostic relevance. Leukemia (2012) 0.96
Exclusion of a major role for the PTEN tumour-suppressor gene in breast carcinomas. Br J Cancer (1999) 0.96
Loss of heterozygosity on chromosome 6q14-q24 is associated with poor outcome in children and adolescents with T-cell lymphoblastic lymphoma. Leukemia (2006) 0.96
Radiation-induced chromosome aberrations in Saccharomyces cerevisiae: influence of DNA repair pathways. Genetics (1998) 0.95
Molecular cytogenetic detection of chromosomal breakpoints in T-cell receptor gene loci. Leukemia (2003) 0.94
Obesity as an independent risk factor for decreased survival in node-positive high-risk breast cancer. Breast Cancer Res Treat (2015) 0.94
Stable and reproducible engraftment of primary adult and pediatric acute myeloid leukemia in NSG mice. Leukemia (2011) 0.94
Study participation improves treatment strategies and individual patient care in participating centers. Anticancer Res (2006) 0.93
Golabi-Ito-Hall syndrome results from a missense mutation in the WW domain of the PQBP1 gene. J Med Genet (2006) 0.93
Chromosomal aberrations in congenital bone marrow failure disorders--an early indicator for leukemogenesis? Ann Hematol (2007) 0.92
TEGDMA causes apoptosis in primary human gingival fibroblasts. J Dent Res (2003) 0.92
Treatment of lupus-prone NZB/NZW F1 mice with recombinant soluble Fc gamma receptor II (CD32). Ann Rheum Dis (2007) 0.92
The human immunoglobulin kappa locus. Characterization of the duplicated O regions. Eur J Immunol (1991) 0.92
Analysis of NUP98/NSD1 translocations in adult AML and MDS patients. Leukemia (2012) 0.92
Clinical utility of kallikrein-related peptidases (KLK) in urogenital malignancies. Thromb Haemost (2013) 0.92
Frequent deletions of 6q23-24 in B-cell non-Hodgkin's lymphomas detected by fluorescence in situ hybridization. Genes Chromosomes Cancer (1997) 0.91
Subjective and objective perception of upper incisors. J Oral Rehabil (2006) 0.91
MR-guided intervention in women with a family history of breast cancer. Eur J Radiol (2005) 0.91
Regional localization of two MRX genes to Xq28 (MRX28) and to Xp11.4-Xp22.12 (MRX33). Am J Med Genet (1996) 0.91
Bone loss in premenopausal, perimenopausal and postmenopausal women: results of a prospective observational study over 9 years. Climacteric (2012) 0.90
The TP53 Arg72Pro and MDM2 309G>T polymorphisms are not associated with breast cancer risk in BRCA1 and BRCA2 mutation carriers. Br J Cancer (2009) 0.90
Influence of pattern of menopausal transition on the amount of trabecular bone loss. Results from a 6-year prospective longitudinal study. Maturitas (2006) 0.90
Mutation analysis of p53 in ovarian tumors by DHPLC. J Biochem Biophys Methods (2001) 0.90
A new genetic locus for X linked progressive cone-rod dystrophy. J Med Genet (2003) 0.89
Detection of the t(14;18) chromosomal translocation by interphase cytogenetics with yeast-artificial-chromosome probes in follicular lymphoma and nonneoplastic lymphoproliferation. J Clin Oncol (1996) 0.89
FISH-microdissection (FISH-MD) analysis of complex chromosome rearrangements. Cytogenet Cell Genet (2000) 0.89
Long-range map of a 3.5-Mb region in Xp11.23-22 with a sequence-ready map from a 1.1-Mb gene-rich interval. Genome Res (1996) 0.89
Deletions in the long arm of chromosome 10 in lymphomas with t(14;18): a pathogenetic role of the tumor supressor genes PTEN/MMAC1 and MXI1? Blood (1998) 0.89
Clonal duplication of a germline PTPN11 mutation due to acquired uniparental disomy in acute lymphoblastic leukemia blasts from a patient with Noonan syndrome. Leukemia (2007) 0.89
What kind of habituation is impaired in migraine patients? Cephalalgia (2003) 0.89
Impact of expression differences of kallikrein-related peptidases and of uPA and PAI-1 between primary tumor and omentum metastasis in advanced ovarian cancer. Ann Oncol (2010) 0.88
Report of the European Task Force on Lymphomas: workshop on peripheral T-cell lymphomas. Ann Oncol (1998) 0.88
BTKbase, mutation database for X-linked agammaglobulinemia (XLA) Nucleic Acids Res (1997) 0.88
Global increase in DNA methylation in patients with myelodysplastic syndrome. Leukemia (2008) 0.87
Activation of Evi1 inhibits cell cycle progression and differentiation of hematopoietic progenitor cells. Leukemia (2012) 0.87